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study question: Is perinatal germ cell (GC) differentiation in the marmoset similar to that in the human?
summary answer: In a process comparable with the human, marmoset GC differentiate rapidly after birth, losing OCT4 expression
after 5–7 weeks of age during mini-puberty.
what is known already: Most of our understanding about perinatal GC development derives from rodents, in which all gono-
cytes (undifferentiated GC) co-ordinately lose expression of the pluripotency factor OCT4 and stop proliferating in late gestation. Then after
birth these differentiated GC migrate to the basal lamina and resume proliferation prior to the onset of spermatogenesis. In humans, fetal GC
differentiation occurs gradually and asynchronously and OCT4+ GC persist into perinatal life. Failure to switch off OCT4 in GC perinatally
can lead to development of carcinoma in situ (CIS), the precursor of testicular germ cell cancer (TGCC), for which there is no animal model.
Marmosets show similarities to the human, but systematic evaluation of perinatal GC development in this species is lacking. Similarity,
especially for loss of OCT4 expression, would support use of the marmoset as a model for the human and for studying CIS origins.
study design, size and duration: Testis tissues were obtained from marmosets (n ¼ 4–10 per age) at 12–17 weeks’
gestation and post-natal weeks 0.5, 2.5, 5–7, 14 and 22 weeks, humans at 15–18 weeks’ gestation (n ¼ 5) and 4–5 weeks of age
(n ¼ 4) and rats at embryonic day 21.5 (e21.5) (n ¼ 3) and post-natal days 4, 6 and 8 (n ¼ 4 each).
participants/materials, setting and methods: Testis sections from fetal and post-natal marmosets, humans and
rats were collected and immunostained for OCT4 and VASA to identify undifferentiated and differentiated GC, respectively, and for
Ki67, to identify proliferating GC. Stereological quantiﬁcation of GC numbers, differentiation (% OCT4+ GC) and proliferation were per-
formed in perinatal marmosets and humans. Quantiﬁcation of GC position within seminiferous cords was performed in marmosets,
humans and rats.
main results and role of chance: The total GC number increased 17-fold from birth to 22 post-natal weeks in marmo-
sets; OCT4+ and VASA+ GC proliferated equally in late gestation and early post-natal life. The percentage of OCT4+ GC fell from 54%
in late fetal life to ,0.5% at 2.5 weeks of age and none were detected after 5–7 weeks in marmosets. In humans, the percentage of
OCT4+ GC also declined markedly during the equivalent period. In marmosets, GC had begun migrating to the base of seminiferous
cords at 22 weeks of age, after the loss of GC OCT4 expression.
limitations, reasons for caution: There is considerable individual variation between marmosets. Although GC
development in marmosets and humans was similar, there are differences with respect to proliferation during fetal life. The number
of human samples was limited.
& The Author 2013. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
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wider implications of the findings: The similarities in testicular GC differentiation between marmosets and humans
during the perinatal period, and their differences from rodents, suggest that the marmoset may be a useful model for studying the
origins of CIS, with relevance for the study of TGCC.
study funding/competing interests: This work was supported by Grant G33253 from the Medical Research Council,
UK. No external funding was sought and there are no competing interests.
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Introduction
The male common marmoset (Callithrix jacchus) has been proposed as
a more appropriate model than rodents for study of human testicular
function, in particular for studies on fetal and neonatal germ cell (GC)
development and differentiation. The marmoset and human are
broadly similar in terms of overall testis development and function.
Both species exhibit a neonatal surge in gonadotrophin and reproduct-
ive hormonal activity, now generally termed as ‘mini-puberty’. This
lasts from birth until 12–15 weeks of age in the marmoset, with a
peak in plasma testosterone levels at around 2–3 weeks of age
(Dixson, 1986; Lunn et al., 1994; McKinnell et al., 2001), and from
1 month until 4–6 months of age in the human, peaking at around
2 months of age (Forest et al., 1974; Job et al., 1988; Gustafson
et al., 1993). This is followed by an extended period of ‘childhood’ qui-
escence (Chemes, 2001; Kelnar et al., 2002), which does not occur in
the rodent (Plant, 2006). In addition, subsequent organization and ef-
ﬁciency (number of GC supported per Sertoli cell) of spermatogenesis
is similar in adult marmosets and humans but notably different in
rodents (Sharpe, 1994; Millar et al., 2000; Sharpe et al., 2000; Wein-
bauer et al., 2001).
There are other signiﬁcant differences between rodents and pri-
mates, particularly in relation to GC development during perinatal
life. In the rat, gonocytes (undifferentiated GC) enter a period of
proliferative quiescence at around e17–e18 and do not recommence
proliferation until a few days after birth (More´no et al., 2001; Ferrara
et al., 2006; Jobling et al., 2011). Also, GC differentiation in rodents is
synchronous; for example, all GC in the rat coordinately lose expres-
sion of the pluripotency marker OCT4, so that by e19 OCT4-positive
GC are absent (Ferrara et al., 2006; Jobling et al., 2011). In contrast, in
humans and marmosets there is no stage of fetal GC proliferative qui-
escence (Honecker et al., 2004; Mitchell et al., 2008), and the fetal GC
population is heterogeneous and differentiates asynchronously
throughout fetal life and the neonatal period (Gaskell et al., 2004;
Mitchell et al., 2008; McKinnell et al., 2009). Thus, individual seminifer-
ous cords contain undifferentiated (OCT4 positive/VASA negative)
and differentiated (OCT4 negative/VASA positive) GC side by side
from mid-gestation until the ﬁrst few weeks of life. However, there
are conﬂicting data from the marmoset regarding the precise degree
to which expression of OCT4 and other markers of undifferentiated
GC persists after birth. Studies from our own laboratory suggest that
pluripotency factors OCT4 and NANOG and the transcription
factor AP2gamma share a very similar pattern of GC expression, all de-
clining gradually during the ﬁrst 6 weeks after birth (Mitchell et al.,
2008). In contrast, Albert et al. (2010) reported that the GC population
expressing OCT4 and AP2gamma is stable, with numbers remaining
constant until at least 8 weeks of age. This question is of particular
importance because OCT4, AP2gamma and NANOG are also
markers of carcinoma in situ (CIS), the precursor of testicular germ
cell cancer (TGCC) in humans (Rajpert-de Meyts, 2006). It is
thought that CIS arises because of a failure of some GC to switch off
expression of such undifferentiated GC factors (Rajpert-de Meyts,
2006), and the asynchronous nature of GC differentiation in humans
may predispose towards this. The incidence of TGCC is increasing in
Western countries (Bray et al., 2006), but investigation of potential
factors underlying its occurrence is hampered by poor understanding
of perinatal GC development (Culty, 2009) and the lack of an appro-
priate animal model.
Most of our understanding about regulation of GC development and
differentiation derives from rodents while relatively little is known in pri-
mates. As a consequence, the default assumption is that GC develop-
ment occurs as in rodents. For example, at around post-natal day
(pnd) 6 in rats, GC migrate from the centre of seminiferous cords to
make contact with the basal lamina, a step which is essential for their
differentiation into spermatogonia and for proliferation to recommence
(Roosen-Runge and Leik, 1968; McGuinness and Orth, 1992). It is
assumed that the same process is required in primates, but when this
occurs is unclear, nor is it known for certain whether GC migration
occurs subsequent to the loss of expression of pluripotency markers,
as in the rodent, or whether these two aspects of differentiation
overlap. This question is of interest in the context of CIS/TGCC,
because in the normal human testis during the perinatal period, those
GC which remain OCT4 positive are almost exclusively located in
the centre of the seminiferous cords (Honecker et al., 2004; Cools
et al., 2005). On the other hand, in older children with disorders of
sexual development or undervirilization, who are at increased risk of
TGCC, GC expressing OCT4 are reported to be both more numerous
and located at the basal lamina (Cools et al., 2005; Hersmus et al.,
2012). The marmoset may be a human-relevant model in which to
address these issues. A number of studies have analysed GC number,
differentiation (Sharpe et al., 2000, 2002, 2003; McKinnell et al.,
2009; Albert et al., 2010) and proliferation (Kelnar et al., 2002; Mitchell
et al., 2008; McKinnell et al., 2009) at speciﬁc timepoints during peri-
natal life in the marmoset, but the conﬂicting marmoset data mentioned
above highlight the need for a comprehensive quantitative study of
these parameters spanning the period from fetal life through to the
end of mini-puberty. The aims of the present study were therefore:
ﬁrstly, to analyse and delineate more precisely the normal course of
male GC development in the marmoset during this period, with
regard to proliferation, differentiation and migration; secondly, using
OCT4 expression as a marker, to address in particular the inconsist-
ency in existing data regarding the persistence of undifferentiated GC
after birth; and thirdly, by comparison with the human and the rat, to
evaluate whether or not the marmoset is a potentially suitable model
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for the human, especially in relation to the perinatal origins of CIS, the
precursor of TGCC.
Materials and Methods
Animals
Common marmoset monkeys (Callithrix jacchus) were captive-bred and
maintained in a closed colony that has been self-sustaining since 1973.
Wistar rats were maintained in our own animal facility according to UK
Home Ofﬁce guidelines. Studies were performed according to the
Animal (Scientiﬁc Procedures) Act 1986 under UK Home Ofﬁce Project
Licence approval, and also approved by the local ethical committee for
studies in primates.
Tissue collection and processing
Marmoset fetal testes
Testes were obtained from the fetuses of pregnant marmosets in the
colony breeding stock that were being euthanized for colony management
purposes. Gestation in the marmoset lasts for 144 days (Windle et al.,
1999). The gestation of pregnant females was assessed by systematic pal-
pation and/or ultrasound. Experience has shown this to be accurate within
1 week and was subsequently conﬁrmed by time of birth. Mothers and
fetuses were euthanized by injection of an overdose of sodium pentobar-
bitone (Euthatal; Rhone Merieux Ltd, Harlow, Essex, UK). The fetuses
(12–17 weeks, n ¼ 5) were delivered by hysterotomy. Fetuses were
ﬁxed in Bouins for 6 h (larger fetuses were partially dissected prior to
ﬁxing) and then transferred to 70% ethanol.
Marmoset post-natal testes
Testes at0.5weeks (1–5 days, n ¼ 10),2.5weeks (17–20 days, n ¼ 5),
5–7 weeks (n ¼ 9), 14 weeks (n ¼ 4) and 22 weeks (n ¼ 6) of age were
from control animals that had been used for previous studies, in order to
reduce the animal numbers required (Lunn et al., 1997; Kelnar et al.,
2002; Sharpe et al., 2002, 2003; McKinnell et al., 2009); in addition, some
testes were from animals euthanized for colony management purposes.
All testes were ﬁxed as described above, prior to processing.
Human fetal testes
Testes were obtained following termination of pregnancy at 15–18 weeks’
gestation (n ¼ 5). Women gave consent in accordance with national guide-
lines (Polkinghorne, 1989), and ethical approval was obtained from the
Local Research Ethics Committee. No terminations were due to fetal ab-
normalities. Gestational age was determined initially by ultrasound exam-
ination, followed by direct measurement of foot length. Testes were ﬁxed
for 2 h in Bouins and then transferred into 70% ethanol prior to
processing.
Human post-natal testes
Testes were obtained at autopsy with consent of their legal guardian
(courtesy of K. McKenzie, Department of Pathology, Royal Inﬁrmary of Ed-
inburgh) from boys (n ¼ 4) who died at 4–5 weeks of age from various
causes (excluding reproductive and endocrine abnormalities). Testes
were ﬁxed in 10% neutral-buffered formalin for at least 24 h and processed
as below.
Rat fetal testes
Pregnant dams were killed by inhalation of carbon dioxide when their
fetuses had reached e21.5 (n ¼ 3). Fetuses were removed, decapitated
and placed in ice-cold phosphate-buffered saline (PBS; Sigma, Poole,
UK). Testes were removed via microdissection and ﬁxed for 1 h in
Bouins followed by transfer into 70% ethanol.
Rat post-natal testes
Male rats aged 4, 6 and 8 days (n ¼ 4 at each age) were anaesthetized by
CO2 inhalation and then killed by cervical dislocation. Testes were
removed, ﬁxed for 6 h in Bouins and transferred into 70% ethanol.
Tissue processing
All ﬁxed testes were embedded in parafﬁn wax using standard methods in
an automatic processor (Leica Microsystems, Milton Keynes, UK) and sec-
tions of 5 mm thickness were prepared.
Immunohistochemistry
Speciﬁc proteins were detected by immunohistochemistry using methods
detailed previously (Gaskell et al., 2004; Ferrara et al., 2006; Mitchell et al.,
2008). An antibody against VASA (ab13840; Abcam, Cambridge, UK) was
used at a dilution of 1:200; antibodies against OCT4 (sc-8628; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and Ki67 (M7240; Dako, Ely, UK)
were used at 1:40. Brieﬂy, antigen retrieval used 0.01 M Citrate buffer,
pH 6.0. Endogenous peroxidase was blocked by incubating slides for
30 min in 3% (vol/vol) H2O2 in methanol and endogenous biotin was
blocked using a streptavidin/biotin blocking kit (Vector Laboratories
Inc., Peterborough, UK) according to the manufacturer’s instructions.
Non-speciﬁc binding was blocked by incubating slides in appropriate
normal serum diluted 1:5 in TBS containing 5% (w/v) bovine serum
albumen (BSA; Sigma). After incubation overnight at 48C with primary
antibody, slides were washed in TBS then incubated with appropriate
biotinylated secondary antibody, followed by incubation with streptavidin-
conjugated horseradish peroxidase (Dako) and visualization of immunos-
taining using diaminobenzidine (Liquid DAB+; Dako).
Double immunostaining using fast blue
visualization
VASA/OCT4
After incubation with the primary (VASA) and secondary antibodies as
described above, slides were washed in TBS, incubated with streptavidin-
conjugated alkaline phosphatase (Dako) diluted 1:200 in TBS, and immu-
nostaining was visualized using 1 mg/ml Fast Blue (Sigma-Aldrich Ltd,
Poole, UK) until staining was optimal. After washing in TBS, slides were
immunostained for OCT4 using DAB visualization as described above.
Ki67/VASA
Immunostaining for the proliferation marker Ki67, using DAB detection,
was performed as described above. Slides were then washed in TBS
and immunostained for VASA using Fast Blue as described above.
To ensure reproducibility of results and accurate comparison of immu-
nostaining, sections from all groups were run in parallel on at least two
occasions. Negative controls were included in each experiment, for
which the primary antibody was replaced with either peptide-preabsorbed
antibody (OCT4) or the appropriate normal serum (VASA, Ki67) and, in
all cases, immunostaining was absent. Representative sections were photo-
graphed using a Provis AX70 microscope (Olympus Optical, London, UK)
ﬁtted with a Canon DS6031 digital camera (Canon Europe, Amsterdam,
The Netherlands). Images were compiled using Photoshop Elements 9
(Adobe Systems Inc., Mountain View, CA, USA).
Triple immunoﬂuorescence
Details of antibodies and detection reagents are shown in Table I. Antigen
retrieval, blocking and incubation with the ﬁrst primary antibody were
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performed as described above for immunohistochemistry. Sections were
incubated with a peroxidase-conjugated secondary antibody diluted in
normal serum/TBS/BSA for 30 min and kept in the dark thereafter.
Slides were then incubated with labelled Tyramide diluted in buffer at
1:50 for 10 min before being placed in boiling citrate buffer and micro-
waved on full power for 2.5 min and left to cool for a further 30 min.
The incubations with primary antibody, peroxidase-conjugated secondary
antibody and Tyramide (with different ﬂuorescent labels) were then
repeated for the second and third primary antibodies. Following incubation
of the second Tyramide label, sections were incubated for 15 min in in 3%
(vol/vol) H2O2 in TBS to block any remaining peroxidase. Sections were
counterstained with 4′,6-diamidino-2-phenylindole (DAPI, Sigma) diluted
1:1000 in PBS for 10 min. Slides were mounted using Permaﬂuor (Immu-
notech, Marseille, France). Slides were scanned and tiled images of com-
plete testis sections were captured using an LSM 710 confocal
microscope and ZEN 2009 software (Carl Zeiss, Hertfordshire, UK).
Determination of GC numbers
Sections were analysed using a Zeiss Axio-Imager microscope (Carl Zeiss
Ltd, Welwyn Garden City, UK) ﬁtted with a Hitachi HV-C20 camera
(Hitachi Denshi Europe, Leeds, UK) and a Prior automatic stage (Prior Sci-
entiﬁc Instruments Ltd, Cambridge, UK). Image-Pro 6.2 with Stereologer
plug-in software (MagWorldwide, Wokingham, UK) was used to select
random ﬁelds for counting and to place a grid over the tissue. GC counting
used sections immunostained for VASA or OCT4. Relative cell volume per
testis was ﬁrst determined by point counting (Sharpe et al., 2003). The
number of ﬁelds counted per animal (15–75 ﬁelds) was dependent
on obtaining a percentage SE value of ,5%. Data were converted to ab-
solute volume per testis by multiplying by testis weight (equivalent to
volume), then converted to cell number per testis after determination
of mean cell nuclear diameter and volume (average of 100 nuclei)
using the Stereologer software nucleator function.
Determination of the GC proliferation index
in the marmoset
GC proliferation in fetal and 0.5-week-old marmoset testes was quantiﬁed
using sections subjected to triple immunoﬂuorescence for OCT4/VASA/
KI67, which enabled identiﬁcation of proliferating and non-proliferating
cells within both OCT4+ and VASA+ GC subpopulations. Confocal
images of complete testis cross-sections (2–3 per animal) were examined
using AxioVision 4.8 software (Carl Zeiss), and all OCT4+/Ki67+,
OCT4+/Ki672, VASA+/Ki67+ and VASA+/Ki672 cells were counted.
For both OCT4+ and VASA+ GC subpopulations, proliferation index
(PI) was calculated as the number of cells which were also Ki67+ in
each subpopulation divided by the total number of each subpopulation,
counted ×100. For marmosets at 14 and 22 weeks of age, the simpler
method of VASA/Ki67 double immunostaining was used, as only
VASA+ GC were present. Stereology was used to select 15–20 ﬁelds at
random from two sections per animal, and a total of 250–300 GC
were counted. The PI was calculated as the number of VASA+/Ki67+
cells divided by the number of Ki67+/VASA+ plus VASA+/Ki672 cells
×100.
Percentage of GCs expressing OCT4 in the
marmoset and human
Using the data for GC numbers determined as described earlier, the per-
centage of OCT4+ GC in post-natal marmosets was calculated as the
number of OCT4+ cells divided by the total number of GC (OCT4+
plus VASA+), ×100. In fetal marmosets and in the human, we were
unable to calculate absolute numbers of GC as data for testis volume/
weight was unavailable. We therefore used stereology to analyse sections
double-immunostained for OCT4 and VASA (fetal marmosets) or sections
immunostained for OCT4 only (humans). In the latter, we identiﬁed
immunonegative GC on the basis of their morphology. We used stereol-
ogy to select random ﬁelds, and counted 200 GC from 2–3 sections per
individual, then determined the proportion of OCT4+/VASA2 or OCT4+
cells as a percentage of total GC counted.
Determination of GC position in the
marmoset, human and rat
As a measure of GC development, we analysed the GC complement in
terms of their position within the seminiferous cords and to compare
the marmoset, human and the rat for this parameter. On pairs of serial
sections immunostained for VASA and OCT4, we identiﬁed GC that
were centrally located (no part of the cell having any contact with the
basal lamina), in partial contact with the basal lamina (only a small part
of cell cytoplasm in contact), and basally located (with the cell nucleus
and/or a large part of the cytoplasm in close contact with the basal
lamina). These criteria are illustrated in Fig. 1. We used stereology to
select random ﬁelds and a minimum of 150 VASA+ cells, from two sec-
tions per testis, were counted at each age. For testes from fetal and
0.5-week-old marmosets and from the fetal human, we also counted a
minimum of 150 OCT4+ cells, from two sections per testis. However,
in marmosets at 2.5 weeks and 5–7 weeks of age, because OCT4+
cells were much fewer in number, we used sections from all animals
and several immunostaining runs in order to count a pooled total 55
cells at both these ages. For each GC subpopulation, the proportion of
cells in each position was then calculated as a percentage of the total
number of VASA+ or OCT4+ cells counted.
Statistical analysis
Data were analysed using Student’s t-test (two-tailed), except for
between-age comparisons of data for GC position, for which one-way
analysis of variance was used.
Results
GC numbers in the marmoset
Fetal marmoset and human testes contain a heterogeneous population
of undifferentiated and differentiated GC (Gaskell et al., 2004; Mitchell
et al., 2008), with some undifferentiated GC persisting into neonatal
life (Mitchell et al., 2008; McKinnell et al., 2009). We have previously
........................................................................................
Table I Antibodies and conditions for triple
immunoﬂuorescence.
Antigen Dilution Secondary antibody Visualization
OCT4 1:100 aCAG-p dTyr-Cy3
VASA 1:100 bCAR-p eTyr Fluor
Ki67 1:100 cCAM-p fTyr-Cy5
aCAG-p—Chicken anti-goat peroxidase (Santa Cruz Biotechnology, CA, USA).
bCAR-p—Chicken anti-rabbit peroxidase (Santa Cruz).
cCAM-p—Chicken anti-mouse peroxidase (Santa Cruz).
dTyr-Cy3—Tyramide Cy3 (Perkin Elmer, MA, USA).
eTyr Fluor—Tyramide Fluorescien (Perkin Elmer).
fTyr-Cy5—Tyramide Cy5 (Perkin Elmer).
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published data for total GC numbers, i.e. undifferentiated (OCT4+)
plus differentiated (VASA+) GC, in 1–5-day-old (0.5 week) marmo-
sets and the number of VASA+ GC at 17–20 days (2.5 weeks) of
age (McKinnell et al., 2009). In order to more systematically investigate
the dynamics and differentiation of the GC population in marmosets
throughout the neonatal period, we have now examined OCT4 and
VASA immunoexpression at 2.5, 5–7, 14 and at 22 weeks of age
(Fig. 2) and quantiﬁed both VASA+ and OCT4+ cells at each age.
For the purposes of comparison, we have included the data on GC
numbers from McKinnell et al. (2009) in Table II. Total GC number
per testis (OCT4+ plus VASA+) at 2.5 weeks was 1.64 × 106
(Table II), an increase of 2.7-fold compared with 0.5 weeks of age.
This increase was due entirely to an increase in VASA+ GC, as
numbers of OCT4+ GC decreased rapidly after birth. Only 0.006 ×
106 OCT4+ GC per testis were present at 2.5 weeks of age
(Table II), compared with 0.082 × 106 which we had found previously
at 0.5 weeks of age (Table II), and in one out of ﬁve animals examined
at 2.5 weeks of age no OCT4+ GC were detected (not shown). Total
GC numbers changed only slightly between 2.5 and 5–7 weeks of age,
while OCT4+ GC numbers declined further to 0.004 × 106 per testis
at 5–7 weeks (Table II) and in four out of nine animals at this age
OCT4+ GC were undetectable (not shown). Thereafter, no
OCT4+ GC were detected in any animals. Beyond 5–7 weeks, GC
numbers increased 1.9-fold to reach 3.77 × 106 by 14 weeks, then
rose another 2.5-fold between 14 and 22 weeks of age to 9.76 ×
106 (Table II). Between 0.5 and 22 weeks, the GC number increased
17-fold (Table II).
GC proliferation in the marmoset
Since GC proliferation in the human fetal testis is reported to occur
predominantly in the OCT4+ subpopulation (Mitchell et al., 2010),
we set out to determine if this is also the case in the marmoset.
We used OCT4/VASA/Ki67 triple immunostaining and confocal mi-
croscopy to quantify proliferation in OCT4+ and VASA+ subpopula-
tions in the fetal and neonatal marmoset (Fig. 3A). While previous
studies in fetal and immature marmosets have shown that GC prolif-
eration was present at all timepoints studied up to 6 weeks of age
(Mitchell et al., 2008; McKinnell et al., 2009), data for later post-natal
ages are lacking. Therefore, the present study also utilized VASA/Ki67
double immunostaining to extend the investigation of GC proliferation
to 14 and 22 weeks of post-natal life (Fig. 3A). We found that the
overall GC PI in fetal testes was 29.1% (Fig. 3B), and there was no dif-
ference in PI between OCT4+ (28.9%) and VASA+ (29.9%) subpopu-
lations (Fig. 3B). In the ﬁrst week of post-natal life, the overall PI
declined signiﬁcantly to 13.3% (Fig. 3B) and again there was no differ-
ence in PI between the OCT4+ (12.2%) and VASA+ (13.0%) subpo-
pulations. However, the changes in the PI of each subpopulation
compared with that in fetal life did not reach statistical signiﬁcance.
By 14 weeks of age only VASA+ GC were present, and although pro-
liferation was still detectable, the PI was only 2.7%—signiﬁcantly lower
than the overall PI at 0.5 weeks of age (Fig. 3B). Compared with 14
weeks of age, PI increased signiﬁcantly to 7% at 22 weeks of age
(Fig. 3B).
Proportion of OCT41 GCs in the marmoset
and human testis
We have previously used the percentage of total GC that are OCT4+
as a quantitative measure of GC differentiation in the marmoset
(McKinnell et al., 2009), and in the present study we have further
quantiﬁed the OCT4+ GC population in this manner at different
ages in order to delineate the progression of differentiation. For the
purposes of comparison, the data from McKinnell et al. (2009) are
included in Fig. 4. This also allowed us to compare the neonatal GC
population in marmosets with that in fetal life (for which a calculation
of absolute numbers was not possible) and also to compare fetal and
Figure 1 Photomicrograph of post-natal marmoset testes immu-
nostained for OCT4 or VASA to illustrate the criteria used to identify
germ cells which are centrally located within seminiferous cords
(asterisks; no part of the cell having any contact with the basal
lamina), in partial contact with the basal lamina (arrows; only a
small part of cell cytoplasm in contact) and basally located (arrow-
heads; the cell nucleus and/or a large part of the cytoplasm in
close contact with the basal lamina).
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neonatal marmosets with the human. We found that in marmoset
testes at 12–17 weeks’ gestation, OCT4+ cells comprised almost
54% of the total GC present (Fig. 4). The proportion of GC which
were OCT4+ at 0.5 weeks was only 12.4% (Fig. 4), indicating a rela-
tively rapid rate of differentiation during late pregnancy and around the
time of birth. The proportion of OCT4+ GC continued to decline
rapidly and signiﬁcantly, with only 0.4% of GC being OCT4+ at 2.5
weeks and 0.3% at 5–7 weeks of age (Fig. 4). After this age, no
OCT4+ GC were detected in any animals (Fig. 4). In human fetal
and neonatal testes, the proportion of OCT4+ GC and the progress
of differentiation were remarkably similar to the marmoset. We found
that OCT4+ GC in fetal human testes at 15–18 weeks’ gestation
comprised almost 62% of the total (Fig. 4), but this declined signiﬁcant-
ly to 9% by 4–5 weeks after birth (Fig. 4).
GC position in the marmoset, human and rat
testis
In rodents, migration of GC to the basal lamina at around the time of
birth is considered to be another feature of GC differentiation/matur-
ation (Roosen-Runge and Leik, 1968; McGuinness and Orth, 1992).
We used stereology to analyse the GC complement in terms of
their position within the seminiferous cords, and to compare the mar-
moset, human and rat for this parameter. Using criteria illustrated in
Fig. 1, we assessed the percentage of the VASA+ and OCT4+ GC
subpopulations that were centrally located, in partial contact with
the basal lamina, and basally located. For each species and within
each subpopulation, we found that the proportion of GC in partial
contact with the basal lamina was relatively constant (12–18% in mar-
mosets and humans, 13–20% in rats) at all timepoints, and for ease of
presentation these results are therefore not shown. In considering the
following marmoset GC positional data, it should be remembered that
the proportion of OCT4+ GC declined rapidly after birth with a cor-
responding increase in the proportion of VASA+ GC.
In marmosets at 12–17 weeks of gestation, just under 60% of
VASA+ GC were centrally located, while 26% were basally
located (Fig. 5). Thereafter, the proportion that was centrally
located gradually increased and the proportion basally located
decreased, so that by 5–7 weeks of age 80% of VASA+ GC were cen-
trally located and only 8% were basal; these ﬁgures were signiﬁcantly
different from those at 0.5 weeks of age (Fig. 5). The proportions were
little changed at 14 weeks of age (Fig. 5). However, at 22 weeks of age
the pattern changed dramatically and only 40% of VASA+ GC were
centrally located, while the same proportion was located basally
(Fig. 5). Again, both percentages were signiﬁcantly different compared
with 0.5 weeks of age (Fig. 5). At 12–17 weeks of gestation and at 0.5
Figure 2 Immunoexpression of GC markers OCT4 and VASA in testes from post-natal marmosets. OCT4+ cells were already rare at 2.5 weeks of
age and were not detected in any animals after 5–7 weeks of age. Scale bar ¼ 20 mm.
........................................................................................
Table II Age-related change in numbers (106) of
VASA1 and OCT41 GC in post-natal marmoset testes.
No OCT41 cells were detected (ND) after 5–7 weeks of
age.
VASA1 OCT41 Total
0.5 weeksa 0.494+0.101 0.082+0.045 0.576+0.139
2.5 weeks 1.631+0.195 0.006+0.002 1.637+0.195
5–7 weeks 2.018+0.331 0.004+0.002 2.022+0.330
14 weeks 3.772+0.735 ND 3.772+0.735
22 wks 9.765+1.048 ND 9.765+1.048
Values are means+ SEM. 0.5 weeks n ¼ 10; 2.5 weeks n ¼ 5; 5–7 weeks n ¼ 9; 14
weeks n ¼ 4; 22 weeks n ¼ 6.
aData taken from McKinnell et al. (2009).
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weeks of age, OCT4+ GC were more evenly distributed between
central and basal locations than were the VASA+ GC, with 40%
in each location (Fig. 5). However, the proportion of centrally
located OCT4+ GC then increased rapidly and by 5–7 weeks of
age 74% were centrally located and only 12% were basal (Fig. 5),
after which OCT4+ GC were undetectable.
In the fetal human testis at 15–18 weeks’ gestation, in contrast to the
fetal marmoset, only a minority (16%) of VASA+ GC were centrally
located, while just over 70% were basally located (Fig. 5). Conversely,
55% of OCT4+ GC were centrally located and only 33% were basal
(Fig. 5).
In the rat testis, OCT4+ GC are absent by e19.5 (Ferrara et al.,
2006; Jobling et al., 2011), and all GC are VASA+ at all ages in the
rat, including when OCT4 is expressed. At e21.5 in the rat almost
80% of GC were centrally located, and ,3% were basal, and these
proportions remained almost unchanged at pnd 4 (Fig. 5). Compared
with 4 days of age, the proportions then changed dramatically and sig-
niﬁcantly, with over 70% of GC becoming basally located by 8 days of
age (Fig. 5), reﬂecting their migration to the basal membrane. At that
age, only 12% of GC remained centrally located (Fig. 5).
Discussion
For reasons set out in the Introduction, the primary goal of the
present studies was to characterize testicular GC development (loss
of pluripotency, proliferation, location within seminiferous cords)
Figure 3 (A) Triple immunoﬂuorescence for OCT4 (red), VASA (green) and Ki67 (blue) was used to identify proliferation in OCT+ and VASA+
germ cell (GC) subpopulations in fetal (F) marmoset testes at 12–17 weeks’ gestation and in post-natal testes at 0.5 weeks of age. Double immu-
nostaining for VASA (blue) and Ki67 (brown) was used to identify proliferating GC at 14 and 22 weeks of age, when OCT4+ cells were no longer
present. Co-localization of OCT4 and Ki67 in GC nuclei (arrows) and Ki67 staining in nuclei of VASA+ GC (arrowheads) is evident. Scale
bar ¼ 20 mm. (B) Overall GC proliferation index (PI) and PI in OCT4+ and VASA+ GC subpopulations in testes from marmosets at 12–17
weeks’ gestation (n ¼ 5) and at 0.5 weeks of age (n ¼ 5), and in VASA+ GC at 14 weeks (n ¼ 4) and 22 weeks of age (n ¼ 6). Values are means+
SEM. **P, 0.01 compared with 12–17 weeks (F) or to 14 weeks. ‡P, 0.05 compared with overall PI at 0.5 weeks of age.
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from late fetal life beyond the end of mini-puberty in the marmoset,
and to compare this with the human and rat. Our results show un-
equivocally that GC differentiation/loss of pluripotency in marmosets
is remarkably similar to that in the human, supporting the use of mar-
mosets for the study of early GC development, for example the peri-
natal origins of CIS/TGCC in men. Our ﬁndings also strongly reafﬁrm
previous conclusions (Ehmcke et al., 2006; Mitchell et al., 2008) that
GC development in rodents is fundamentally different from that in
the human and marmoset, and more cognizance needs to be taken
of this when extrapolating the results from rodent studies into
humans.
In order to investigate the dynamics of GC development, we have
extended our earlier study (McKinnell et al., 2009), and quantiﬁed
both OCT4+ and VASA+ populations from 2.5 weeks until 22
weeks of age. The former timepoint is the reported peak of mini-
puberty in marmosets from our colony, whereas the latter timepoint
is after the end of mini-puberty (Lunn et al., 1994; McKinnell et al.,
2001). The number of OCT4+ GC declined rapidly in the early
Figure 4 Percentage of total GC number which were OCT4+—a measure of GC differentiation—in testes from fetal (F) and post-natal marmosets
and humans. Data for 0.5-week-old marmosets is taken from McKinnell et al. (2009) and is included for comparison. Values are means+ SEM.
Marmosets: 12–17 weeks (F) n ¼ 5; 0.5 weeks n ¼ 10; 2.5 weeks n ¼ 5; 5–7 weeks n ¼ 9; 14 weeks n ¼ 4; 22 weeks n ¼ 6. Human: 15–18
weeks (F) n ¼ 5; 4–5 weeks n ¼ 4. *P, 0.05; **P, 0.01, in comparison with values at 0.5 weeks (marmosets) or in fetal life (humans).
Figure 5 Percentage of OCT4+ and VASA+ GCs found to be centrally or basally located within seminiferous cords in testes from fetal (F) and
post-natal marmoset, fetal human and fetal and post-natal rat. Values are means+ SEM. Marmosets: 12–17 weeks (F) n ¼ 5; 0.5 weeks n ¼ 9;
2.5 weeks n ¼ 5; 5–7 weeks n ¼ 5; 14 weeks n ¼ 4; 22 weeks n ¼ 4. Human: 15–18 weeks (F) n ¼ 5; 4–5 weeks n ¼ 4. Rat: e21 n ¼ 3; 4 days
n ¼ 4; 6 days n ¼ 4; 8 days n ¼ 4. In the marmoset and rat, data at other timepoints were compared with 0.5 weeks or 4 days of age respectively
(arrows). *P, 0.05; **P, 0.001; ***P, 0.0001.
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neonatal period, and by 5–7 weeks of age only 0.004 × 106 OCT4+
GC per testis were present (with no OCT4+ GC identiﬁed in 4/9
animals), compared with 0.08 × 106 at 0.5 weeks of age (McKinnell
et al., 2009). Thereafter, no OCT4+ GC were detected in any
animals. VASA+ GC numbers increased progressively at each time-
point, reaching 9.76 × 106 per testis at 22 weeks of age compared
with 0.57 × 106 just after birth (McKinnell et al., 2009), a 17-fold in-
crease. Our results conﬁrm in quantitative terms the observations of
Mitchell et al. (2008) that GC-expressing OCT4, and other undifferen-
tiated GC markers such as AP2gamma and NANOG, become
progressively less frequent during gestation and early post-natal life,
such that their expression persists in only a few scattered GC at
around 6 weeks of age. However, the present ﬁndings are in contrast
to those of Albert et al. (2010) who reported that the numbers of
OCT4+ and AP2gamma+ GC in marmosets remained unchanged at
8 weeks of age compared with newborn animals. Although a degree
of individual variation between animals is well known in marmosets,
we emphasize that OCT4+ GC are already undetectable in a propor-
tion of animals at 5–7 weeks of age and that after this age we cannot
detect OCT4+ GC in any animals. We note that the OCT4 antibody
used by Albert et al. is reported to be capable of producing
false-positive results in testis-derived cells, whereas the antibody
used in the present study does not (Warthemann et al., 2012). It is
possible that this factor, together with differences in counting
methods, could account for the discrepancy between the two
studies. Our present results also ﬁt with the documented
absence of OCT4+ GC in adult male marmosets (McKinnell
et al., 2009; Albert et al., 2010), as in humans (Rajpert-de Meyts
et al., 2004).
Mitchell et al. (2008) reported that GC proliferation was present at
all stages of fetal and early post-natal life examined in marmosets, al-
though proliferation in the OCT4+ and the VASA+ subpopulations
was not distinguished. In the present study, we found that OCT4+
and VASA+ GC proliferated at similar rates in the fetal marmoset
testis. This was a surprising difference to the ﬁrst and second trimester
human fetal testis, in which GC proliferation occurs predominantly in
the OCT4+ population (Mitchell et al., 2010). On the other hand,
Honecker et al. (2004) reported the presence of proliferation in
roughly equal numbers of undifferentiated and differentiated GC
after 26 weeks of gestation in human pregnancy. In the ﬁrst week
after birth, overall GC proliferation in marmosets declined to less
than half the rate during gestation, but again the PI for OCT4+ GC
was comparable to VASA+ GC. This is also surprising, because
OCT4+ GC decline rapidly in number between 0.5 and 2.5 weeks
of age, while the VASA+ GC are expanding. It is possible either that
OCT4+ GC lose expression of this marker during the proliferation
cycle and instead become VASA+, or that continuing OCT4+ GC pro-
liferation is counterbalanced by increased apoptosis in this subpopula-
tion. Mitchell et al. (2008) showed that GC proliferation between 1
day and 6 weeks of post-natal life in marmosets varied between 9
and 14%. We have extended this to show that GC proliferation con-
tinues throughout early post-natal life. However, the PI reached a
minimum of ,3% at 14 weeks of age, around the reported end of
mini-puberty (Lunn et al., 1994; McKinnell et al., 2001), before rising
to 7% at 22 weeks of age, when plasma testosterone levels are
reported to be basal (Lunn et al., 1994; McKinnell et al., 2001). To-
gether with our earlier study (Mitchell et al., 2008), these ﬁndings
indicate that the prepubertal primate testis is not truly quiescent
(Chemes, 2001; Kelnar et al., 2002).
Although GC differentiation proceeds gradually during gestation in
marmosets (Mitchell et al., 2008), the present study shows that the
pace of GC differentiation is much more rapid in the perinatal
period than previously supposed. The proportion of GC-expressing
OCT4 declined from 54% in late fetal life to ,0.5% at 2.5 weeks of
age, and OCT4+ GC are absent by the time that mini-puberty is
reported to end (Lunn et al., 1994; McKinnell et al., 2001). Our ﬁnd-
ings also suggest that the continuing expression of OCT4 in GC in
neonatal marmosets represents a slower pace of differentiation in
some individual cells, rather than evidence for the persistence of a
stable subpopulation of pluripotent cells beyond early neonatal life,
as suggested by Albert et al. (2010). In humans, a similar rapid and dra-
matic decline in the proportion of GC-expressing OCT4 was
observed between fetal life and 4–5 weeks of age, suggesting that
the progression of GC differentiation in perinatal humans and marmo-
sets is similar. This interpretation is supported by the ﬁnding that GC
OCT4 expression in boys disappears within a few months of birth
(Rajpert-de Meyts et al., 2004), i.e. by the end of mini-puberty in
the human (Job et al., 1988; Gustafson et al., 1993). That OCT4+
GC disappear rapidly after birth is important, as maturational delay
or failure to switch off expression of pluripotency factors in some
GC in the human, may predispose such cells to becoming CIS/
TGCC (Cools et al., 2005; Rajpert-de Meyts, 2006; Hersmus et al.,
2012). Our results suggest that the marmoset may be a useful
animal model for perinatal GC development during the period when
CIS cells are believed to arise.
A feature of early GC maturation in rodents is their migration within
the seminiferous cords. Soon after birth the GC migrate from the
centre of the cords to make contact with the basal membrane. This
step occurs just prior to recommencement of proliferation, and is es-
sential in order for further GC development to occur (Roosen-Runge
and Leik, 1968; McGuinness and Orth, 1992; Nagano et al., 2000).
GC differentiation status in marmosets/humans has been described
previously according to their position within the cord (Sharpe et al.,
2003) or by their expression of pluripotency and/or differentiated
GC markers (Gaskell et al., 2004; Mitchell et al., 2008; McKinnell
et al., 2009; Albert et al., 2010). However, as far as we are aware
there have been no quantitative studies in either species investigating
the relationship between GC differentiation status and their migra-
tion/position. In the present study, we have described the position
of both undifferentiated (OCT4+) and differentiated (VASA+) GC at
several timepoints from late fetal until late neonatal life. We found
that, during late fetal and early neonatal life, marmoset GC are hetero-
geneous in terms of their position, as well as in their differentiation
marker expression (Mitchell et al., 2008; McKinnell et al., 2009).
While OCT4+ GC were distributed roughly equally between basal
and central locations in late gestation, the majority of VASA+ GC
were centrally located, and this pattern remained unchanged immedi-
ately after birth. In the fetal human testis, GC were also heteroge-
neous with regard to position, but in contrast to the marmoset,
VASA+ cells were predominantly basally located whereas the majority
of OCT4+ cells were central. The signiﬁcance of this species differ-
ence is unclear. We were unable to obtain data for GC position at
other timepoints in the human due to the poor morphology of avail-
able tissue. We are therefore unable to establish whether VASA
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expression precedes or follows the alignment of GC with the basal
membrane in humans; however, Honecker et al. (2004) reported
that the progressive relocation of GC to the basal membrane in the
second trimester of pregnancy coincided with increasing intensity of
VASA immunostaining.
The relative distribution of GC in marmosets changed markedly at
2.5 weeks after birth, when both OCT4+ and VASA+ cells were pre-
dominantly centrally located, and by 5–7 weeks 74% of OCT4+ cells
and 80% of VASA+ cells were centrally located. It is striking that these
changes occurred at the same time as OCT4 expression was rapidly
declining. However, it is uncertain as to whether the change in position
is directly related to GC differentiation status, or even whether it is
due to active migration of the GC. In fetal life and just after birth,
the Sertoli cells are dispersed throughout the seminiferous cords
and intermingled with the GC, but later take up a more organized lo-
cation, forming a ring just inside the perimeter of the cords. It may be
that the relocation of GC towards the centre of the cords from 2.5
weeks of age is therefore simply due to their displacement by the
Sertoli cells. The pattern remained unchanged until 22 weeks of age
after the expected end of mini-puberty (Lunn et al., 1994; McKinnell
et al., 2001). At this time the proportion of centrally located VASA+
GC declined to 40%, while the proportion basally located increased
to 40%. In contrast to the marmoset and human, the seminiferous
cords of the late fetal rat testis are much more organized and the
GCs much more homogeneous in terms of position. At this age all
GC are VASA+ and we found that almost 80% were centrally
located and ,3% basal. However, as expected, from 4 days after
birth, GC migrated to make contact with the basal membrane and
by 8 days of age more than 70% were basally located.
Spermatocytes do not appear until 32–35 weeks of age in the mar-
moset (de Souza et al., 1988; Garde et al., 1991; Kelnar et al., 2002),
indicating that GC migration to the basal lamina may be complete by
that time, and more mature GC types are present by 43 weeks (Chan-
dolia et al., 2006). We therefore conclude that the movement of GC
towards the cord periphery in marmosets at 22 weeks of age is analo-
gous to the migration seen in the neonatal rat, and is a precursor of
further GC differentiation. It is notable that this relocation, commen-
cing between 14 and 22 weeks of age, occurs subsequent to the com-
plete loss of GC OCT4 expression, just as it does in the rodent, albeit
over a longer timespan. This may be signiﬁcant, as both Honecker
et al. (2004) and Cools et al. (2005) reported that OCT4+ GC in
normal neonatal humans are almost exclusively located in the centre
of seminiferous cords. In contrast, in boys with disorders of sexual de-
velopment, who are at increased risk of TGCC, OCT4 expression
persists in some GC and these are predominantly located adjacent
to the basal membrane (Cools et al., 2005; Hersmus et al., 2012).
GC identiﬁed as CIS, the precursor of TGCC, are always basally
located (Gondos, 1993). We therefore speculate that loss of OCT4
expression prior to GC migration to the basal membrane is important,
and that persistence of OCT4 expression in some GC, combined with
their abnormal location in the basal niche may, in the human, predis-
pose such GC to becoming CIS. The present ﬁndings in respect of
marmoset GC location/migration strengthen our suggestion that the
marmoset may represent a useful animal model for the study of the
origins of CIS in humans.
In summary, our results show that GC differentiation and relocation
in the perinatal marmoset testis is remarkably similar to that in the
human, and fundamentally different from that in the rat. Much of
this difference may stem from the much more rapid entry of the rat
into puberty and the resulting absence of any period of ‘mini-puberty’
as in the human and marmoset. In particular, the similarities in GC dif-
ferentiation in the early post-natal period in the marmoset and the
human indicate that the marmoset may be a particularly useful
model for studying the regulation of perinatal GC differentiation,
which in the human has direct relevance to the development of CIS,
and thereby TGCC.
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